|
Volumn 27, Issue 4, 2010, Pages 1-30
|
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CHOLINESTERASE INHIBITOR;
OMEGA 3 FATTY ACID;
ALZHEIMER DISEASE;
COGNITION;
COGNITIVE DEFECT;
CONSENSUS DEVELOPMENT;
DIET SUPPLEMENTATION;
DRUG COMBINATION;
DRUG EFFECT;
EVIDENCE BASED MEDICINE;
EXERCISE;
FEEDING BEHAVIOR;
HEALTH;
HUMAN;
METHODOLOGY;
NATIONAL HEALTH ORGANIZATION;
PREVALENCE;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
ALZHEIMER DISEASE;
ANTIHYPERTENSIVE AGENTS;
CHOLINESTERASE INHIBITORS;
COGNITION;
COGNITION DISORDERS;
DIETARY SUPPLEMENTS;
DRUG THERAPY, COMBINATION;
EVIDENCE-BASED MEDICINE;
EXERCISE;
FATTY ACIDS, OMEGA-3;
FOOD HABITS;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PREVALENCE;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
RISK FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
WORLD HEALTH;
|
EID: 84877928840
PISSN: None
EISSN: 15530779
Source Type: None
DOI: None Document Type: Review |
Times cited : (198)
|
References (0)
|